Information  X 
Enter a valid email address

CQS New City HighYld (NCYF)

  Print          Annual reports

Thursday 17 February, 2022

CQS New City HighYld

Issue of Equity

RNS Number : 0563C
CQS New City High Yield Fund Ltd
17 February 2022

17 February 2022


CQS New City High Yield Fund Limited

("the Company")


Issue of Equity


On 17 February 2022 the Company agreed to issue 850,000 ordinary shares of no par value from its blocklisting facility at a price of 55.6 pence per share. The shares will be issued for cash on 21st February 2022.


On the 21st February 2022 the Company's issued share capital will consist of 466,501,858 ordinary shares and there are no shares held in treasury. Therefore, the total number of voting rights in the Company will be 466,501,858.


The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.




For the Investment Manager

New City Investment Managers

Craig Cleland

0207 201 5368


For the Company Secretary and Administrator

BNP Paribas Securities Services S.C.A. Jersey Branch

Dean Plowman / Ryan Gibson

01534 813 967/ 01534 813 996


For the Broker

Nplus1 Singer Advisory LLP

James Maxwell / James Moat (Corporate Finance)

Alan Geeves (Sales)

020 7496 3000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t